Bayban’s CME Group CME Stock Holding History

Bayban’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.4K	Hold	115	–	–	0.02%	306
2026 Q1	$34K	Hold	115	–	–	0.03%	279
2025 Q4	$31.4K	Buy	+115	New	+$31.2K	0.03%	275

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bayban's CME Position: Q2 2026 in Review

Bayban held its CME Group (CME) position steady in Q2 2026 at 115 shares worth $25.4K. The position accounts for 0.02% of the portfolio, ranked #306.

Bayban first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $34K in Q1 2026. 1,613 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Bayban held 115 shares of CME Group worth $25.4K as of Q2 2026.
Bayban left its CME Group share count unchanged in Q2 2026.
CME Group made up 0.02% of Bayban's portfolio in Q2 2026, its #306 holding.
Bayban first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
Bayban's CME Group position peaked at $34K in Q1 2026.
1,613 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.